Your browser doesn't support javascript.
loading
A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV.
Wilck, Marissa; Barnabas, Shaun; Chokephaibulkit, Kulkanya; Violari, Avy; Kosalaraksa, Pope; Yesypenko, Svitlana; Chukhalova, Iryna; Dagan, Ron; Richmond, Peter; Mikviman, Elena; Morgan, Leslie; Feemster, Kristen; Lupinacci, Robert; Chiarappa, Joseph; Madhi, Shabir A; Bickham, Kara; Musey, Luwy.
Afiliación
  • Wilck M; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Barnabas S; Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa.
  • Chokephaibulkit K; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Violari A; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Kosalaraksa P; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Yesypenko S; Odesa Regional Center for Socially Significant Diseases, Odeska Oblast.
  • Chukhalova I; Dnipropetrovsk Regional Medical Center Of Socially Significant Diseases, Dnipro, Ukraine.
  • Dagan R; The Shraga Segal Department of Microbiology, Immunology and Genetics Faculty of Health Sciences of the Ben-Gurion University of the Negev Beer-Sheva, Israel.
  • Richmond P; University of Western Australia, Perth, Australia.
  • Mikviman E; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Morgan L; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Feemster K; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Lupinacci R; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Chiarappa J; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Bickham K; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Musey L; Merck & Co., Inc., Rahway, New Jersey, USA.
AIDS ; 37(8): 1227-1237, 2023 07 01.
Article en En | MEDLINE | ID: mdl-36939067
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Infecciones por VIH Tipo de estudio: Clinical_trials Límite: Child / Humans / Newborn Idioma: En Revista: AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Infecciones por VIH Tipo de estudio: Clinical_trials Límite: Child / Humans / Newborn Idioma: En Revista: AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido